Limited effects on patient outcomes of conjoint tendon release in anterolateral muscle-sparing total hip arthroplasty.


Journal

Journal of orthopaedic surgery and research
ISSN: 1749-799X
Titre abrégé: J Orthop Surg Res
Pays: England
ID NLM: 101265112

Informations de publication

Date de publication:
10 Aug 2021
Historique:
received: 24 06 2021
accepted: 28 07 2021
entrez: 11 8 2021
pubmed: 12 8 2021
medline: 21 12 2021
Statut: epublish

Résumé

The anterolateral muscle-sparing total hip arthroplasty (THA) in the supine position is advantageous owing to the very low-dislocation rate and excellent leg length discrepancy control. However, femur exposure is challenging. Although the conjoined external rotators tendon (CERT) release is effective in improving femoral access, the effects on clinical outcomes remain unclear. The purpose of this study was to evaluate the clinical and radiographic results of CERT release in the anterolateral muscle-sparing THA approach. The study was performed as a retrospective cohort study and included 85 hips in 85 patients who underwent primary anterolateral THA. Clinical and radiographic outcomes were investigated 6 months and 1 year after THA (CERT-preserved and non-released patients). The Japanese Orthopaedic Association (JOA) hip score, JOA Hip-disease Evaluation Questionnaire (JHEQ), forgotten joint score (FJS), and the 36 short-form questionnaires (SF-36 mental and physical) were evaluated. The leg length discrepancy, cup inclination and stem orientation were evaluated with radiographs. Among all the included hips, 37 patients (43.5%) retained the CERT, and 48 patients (56.5%) included the released CERT. There were no significant differences in the JOA hip scores, JHEQ, FJF-12 and SF-36 between the released and non-released groups. There were significant differences in sagittal stem alignments between groups. The CERT release in anterolateral muscle-sparing THA has a limited effect on post-operative clinical outcomes. The CERT release improved the femur exposure and is more invasive than the preserved CERT. We infer that the CERT should be maintained in patients with a wide range of motions, and release the CERT in inadequate femur canal preparation cases.

Sections du résumé

BACKGROUND BACKGROUND
The anterolateral muscle-sparing total hip arthroplasty (THA) in the supine position is advantageous owing to the very low-dislocation rate and excellent leg length discrepancy control. However, femur exposure is challenging. Although the conjoined external rotators tendon (CERT) release is effective in improving femoral access, the effects on clinical outcomes remain unclear. The purpose of this study was to evaluate the clinical and radiographic results of CERT release in the anterolateral muscle-sparing THA approach.
METHODS METHODS
The study was performed as a retrospective cohort study and included 85 hips in 85 patients who underwent primary anterolateral THA. Clinical and radiographic outcomes were investigated 6 months and 1 year after THA (CERT-preserved and non-released patients). The Japanese Orthopaedic Association (JOA) hip score, JOA Hip-disease Evaluation Questionnaire (JHEQ), forgotten joint score (FJS), and the 36 short-form questionnaires (SF-36 mental and physical) were evaluated. The leg length discrepancy, cup inclination and stem orientation were evaluated with radiographs.
RESULTS RESULTS
Among all the included hips, 37 patients (43.5%) retained the CERT, and 48 patients (56.5%) included the released CERT. There were no significant differences in the JOA hip scores, JHEQ, FJF-12 and SF-36 between the released and non-released groups. There were significant differences in sagittal stem alignments between groups.
CONCLUSION CONCLUSIONS
The CERT release in anterolateral muscle-sparing THA has a limited effect on post-operative clinical outcomes. The CERT release improved the femur exposure and is more invasive than the preserved CERT. We infer that the CERT should be maintained in patients with a wide range of motions, and release the CERT in inadequate femur canal preparation cases.

Identifiants

pubmed: 34376238
doi: 10.1186/s13018-021-02644-7
pii: 10.1186/s13018-021-02644-7
pmc: PMC8353803
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

485

Informations de copyright

© 2021. The Author(s).

Références

Clin Orthop Relat Res. 2006 Dec;453:293-8
pubmed: 17006366
Int Orthop. 2019 Jan;43(1):47-53
pubmed: 30284607
J Arthroplasty. 2010 Aug;25(5):687-91
pubmed: 19643564
Eur J Orthop Surg Traumatol. 2015 Oct;25(7):1141-5
pubmed: 26148699
J Orthop Sci. 2006 Nov;11(6):584-91
pubmed: 17139466
Arthroscopy. 2014 Oct;30(10):1235-45
pubmed: 25064755
Clin Orthop Relat Res. 2013 Jul;471(7):2245-52
pubmed: 23412730
Int Orthop. 2018 Feb;42(2):281-287
pubmed: 29285665
J Orthop. 2015 Feb 21;12(Suppl 1):S31-6
pubmed: 26719626
J Orthop Sci. 2012 Jan;17(1):25-38
pubmed: 22045450
J Orthop Sci. 2017 Nov;22(6):1102-1106
pubmed: 28890224
Orthopedics. 2017 Nov 1;40(6):e971-e974
pubmed: 28934544
Hip Int. 2019 Sep;29(5):504-510
pubmed: 31389271
Clin Orthop Relat Res. 2001 Dec;(393):163-7
pubmed: 11764346
Hip Int. 2019 Nov;29(6):578-583
pubmed: 30472892
J Clin Epidemiol. 1998 Nov;51(11):1045-53
pubmed: 9817122
Int Orthop. 2007 Aug;31 Suppl 1:S7-11
pubmed: 17668206
J Arthroplasty. 2012 Mar;27(3):430-436.e1
pubmed: 22000572
Clin Orthop Relat Res. 2012 Jun;470(6):1690-5
pubmed: 22302656
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
BMJ. 2002 Jun 15;324(7351):1417
pubmed: 12065262
Eur J Orthop Surg Traumatol. 2018 Dec;28(8):1625-1632
pubmed: 29951745
J Bone Joint Surg Am. 2001;83-A Suppl 2(Pt 1):2-7
pubmed: 11685838
Clin Orthop Relat Res. 2006 Jun;447:39-42
pubmed: 16741472
J Clin Epidemiol. 1998 Nov;51(11):1037-44
pubmed: 9817121
J Musculoskelet Neuronal Interact. 2013 Mar;13(1):1-12
pubmed: 23445909
Int Orthop. 2016 Dec;40(12):2487-2494
pubmed: 26993647

Auteurs

Hidetatsu Tanaka (H)

Department of Orthopaedic Surgery, Japanse Redcross Sendai Hospital, 43-3, 2 cho-me, yagiyama hon-cho, taihaku-ku, Sendai, 982-8501, Japan. hidetatsu.tanaka@med.tohoku.ac.jp.

Norikazu Yamada (N)

Department of Orthopaedic Surgery, Japanse Redcross Sendai Hospital, 43-3, 2 cho-me, yagiyama hon-cho, taihaku-ku, Sendai, 982-8501, Japan.

Hiroaki Kurishima (H)

Department of Orthopaedic Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.

Yu Mori (Y)

Department of Orthopaedic Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.

Takashi Sakamoto (T)

Department of Orthopaedic Surgery, Japanse Redcross Sendai Hospital, 43-3, 2 cho-me, yagiyama hon-cho, taihaku-ku, Sendai, 982-8501, Japan.

Masamizu Oyama (M)

Department of Orthopaedic Surgery, Japanse Redcross Sendai Hospital, 43-3, 2 cho-me, yagiyama hon-cho, taihaku-ku, Sendai, 982-8501, Japan.

Toshimi Aizawa (T)

Department of Orthopaedic Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH